Glycation of bovine serum albumin by ascorbate in vitro: Possible contribution of the ascorbyl radical?

Redox Biology

Volumn 6, Issue , 2015, Pages 93-99

  Sadowska Bartosz, Izabela ^a   Stefaniuk, Ireneusz ^a   Galiniak, Sabina ^a   Bartosz, Grzegorz ^a,b  

^a UNIVERSITY OF RZESZÓW   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidant; Ascorbic acid; Ascorbyl free radical; Bovine serum albumin; Glycation

Indexed keywords

2,2' AZOBIS 2 METHYL PROPANIMIDAMIDE; AMIDE; ASCORBIC ACID; ASCORBYL RADICAL; BOVINE SERUM ALBUMIN; NITROXIDE DERIVATIVE; POLYPHENOL; RADICAL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; AMIDINE; ANTIOXIDANT; CHELATING AGENT; FREE RADICAL; OXIDIZING AGENT; SOLUTION AND SOLUBILITY;

ANTIOXIDANT ASSAY; ARTICLE; BIOACCUMULATION; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; IN VITRO STUDY; MOLECULAR DYNAMICS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; STEADY STATE; ANIMAL; BOVINE; CHEMISTRY; ELECTRON SPIN RESONANCE; GLYCOSYLATION; OXIDATION REDUCTION REACTION; SOLUTION AND SOLUBILITY; SPECTROFLUOROMETRY;

BOVINAE;

AMIDINES; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CATTLE; CHELATING AGENTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; OXIDANTS; OXIDATION-REDUCTION; POLYPHENOLS; SERUM ALBUMIN, BOVINE; SOLUTIONS; SPECTROMETRY, FLUORESCENCE; SUPEROXIDE DISMUTASE;

EID: 84937208872     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.06.017     Document Type: Article

References (40)

1. Vistoli G., De Maddis D., Cipak A., Zarkovic N., Carini M., Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic. Res. 2013, 47(Suppl. 1):S3-S27. 10.3109/10715762.2013.815348.
2. Aldini G., Vistoli G., Stefek M., Chondrogianni N., Grune T., Sereikaite J., Sadowska-Bartosz I., Bartosz G. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic. Res. 2013, 47(Suppl. 1):S93-S137. 10.3109/10715762.2013.792926.
3. Brubacher D., Moser U., Jordan P. Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int. J. Vitam. Nutr. Res. 2000, 70(5):226-237. 10.1024/0300-9831.70.5.226.
4. Bensch K.G., Fleming J.E., Lohmann W. The role of ascorbic acid in senile cataract. Proc. Natl. Acad. Sci. USA 1985, 82(21):7193-7196.
5. Grandhee S.K., Monnier V.M. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J. Biol. Chem. 1991, 266(18):11649-11653.
6. Vinson J.A., Howard T.B. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 1996, 7(12):659-663. 10.1016/S0955-2863(96)00128-3.
7. Jacques P.F., Taylor A., Hankinson S.E., Willett W., Mahnken B., Lee Y., Vaid K., Lahav M. Long-term vitamin C supplement use and prevalence of early age-related lens opacities. Am. J. Clin. Nutr. 1997, 66(4):911-916.
8. Hegde K.R., Varma S.D. Protective effect of ascorbate against oxidative stress in the mouse lens. Biochim. Biophys. Acta 2004, 1670(1):12-18. 10.1016/j.bbagen.2003.10.007.
9. Fan X., Reneker L.W., Obrenovich M.E., Strauch C., Cheng R., Jarvis S.M., Ortwerth B.J., Monnier V.M. Vitamin C mediates chemical aging of lens crystallins by the Maillard reaction in a humanized mouse model. Proc. Natl. Acad. Sci. USA 2006, 103(45):16912-16917. 10.1073/pnas.0605101103.
10. Linetsky M., Shipova E., Cheng R., Ortwerth B.J. Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins. Biochim. Biophys. Acta 2008, 1782(1):22-34. 10.1016/j.bbadis.2007.10.003.
11. Tupe R.S., Agte V.V. Role of zinc along with ascorbic acid and folic acid during long-term in vitro albumin glycation. Br. J. Nutr. 2010, 103(3):370-377. 10.1016/j.bbadis.2007.10.003.
12. Kisic B., Miric D., Zoric L., Ilic A., Dragojevic I. Antioxidant capacity of lenses with age-related cataract. Oxid. Med. Cell. Longev. 2012, 467130. 2012. 10.1155/2012/467130.
13. Sinclair A.J., Girling A.J., Gray L., Le Guen C., Lunec J., Barnett A.H. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 1991, 34(3):171-175.
14. Toohey J.I. Mercaptopropionaldehyde from homocysteine: implications for Alzheimer's disease. J. Alzheimer's Dis. 2007, 12(3):241-243.
15. Lee P., Wu X. Review: modifications of human serum albumin and their binding effect. Curr. Pharm. Des. 2015, 21(14):1862-1865. 10.2174/1381612821666150302115025.
16. Cao H., Chen T., Shi Y. Glycation of human serum albumin in diabetes: impacts on the structure and function. Curr. Med. Chem. 2015, 22(1):4-13. 10.2174/0929867321666140912155738.
17. Sadowska-Bartosz I., Bartosz G. Ascorbic acid and protein glycation in vitro. Chem. Biol. Interact. 2015, in press.
18. Sadowska-Bartosz I., Galiniak S., Bartosz G. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules 2014, 19(4):4880-4896. 10.3390/molecules19044880.
19. Sadowska-Bartosz I., Galiniak S., Bartosz G. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components. Molecules 2014, 19(11):18828-18849. 10.3390/molecules191118828.
20. Sadowska-Bartosz I., Galiniak S., Skolimowski J., Stefaniuk I., Bartosz G. Nitroxides prevent protein glycoxidation in vitro. Free Radic. Res. 2015, 49(2):113-121. 10.3109/10715762.2014.982113.
21. Henle T., Deppisch R., Beck W., Hergesell O., Hänsch G.M., Ritz E. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol. Dial. Transplant. 1999, 14(8):1968-1975. 10.1093/ndt/14.8.1968.
22. Münch G., Keis R., Wessels A., Riederer P., Bahner U., Heidland A., Niwa T., Lemke H.D., Schinzel R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35(9):669-677.
23. Robaszkiewicz A., Bartosz G., Soszyński M. N-chloroamino acids cause oxidative protein modifications in the erythrocyte membrane. Mech. Ageing Dev. 2008, 129(10):572-579. 10.1016/j.mad.2008.05.007.
24. Rice-Evans C., Diplock A.T., Symons M.C.R. Techniques in Free Radical Research 1991, Elsevier, Amsterdam,London, ISBN 0-444-81304-7.
25. LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309:274-284. 10.1016/S0076-6879(99)09020-5.
26. Bouma B., Kroon-Batenburg L.M., Wu Y.P., Brünjes B., Posthuma G., Kranenburg O., de Groot P.G., Voest E.E., Gebbink M.F. Glycation induces formation of amyloid cross-beta structure in albumin. J. Biol. Chem. 2003, 278(43):41810-41819. 10.1074/jbc.M303925200.
27. Dehghan M., Akhtar-Danesh N., McMillan C.R., Thabane L. Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr. J. 2007, 6:41. 10.1186/1475-2891-6-41.
28. Corti A., Casini A.F., Pompella A. Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch. Biochem. Biophys. 2010, 500(2):107-115. 10.1016/j.abb.2010.05.014.
29. Bürzle M., Hediger M.A. Functional and physiological role of vitamin C transporters. Curr. Top. Membr. 2012, 70:357-375. 10.1016/B978-0-12-394316-3.00011-9.
30. Niki E. Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol. 1990, 186:100-108. 10.1016/0076-6879(90)86095-D.
31. Mehlhorn R.J. Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocyte. J. Biol. Chem. 1991, 266(5):2724-2731.
32. Flamm E.S., Demopoulos H.B., Seligman M.L., Poser R.G., Ransohoff J. Free radicals in cerebral ischemia. Stroke 1978, 9(5):445-447.
33. Vlassopoulos A., Lean M.E., Combet E. Role of oxidative stress in physiological albumin glycation: a neglected interaction. Free Radic. Biol. Med. 2013, 60:318-324. 2013. 10.1016/j.freeradbiomed.2013.03.010.
34. Winterbourn C.C., Peskin A.V., Parsons-Mair H.N. Thiol oxidase activity of copper, zinc superoxide dismutase. J. Biol. Chem. 2002, 277(3):1906-1911. 10.1074/jbc.M107256200.
35. Song Y., Buettner G.R. Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide. Free Radic. Biol. Med. 2010, 49(6):919-962. 10.1016/j.freeradbiomed.2010.05.009.
36. Du J., Cullen J.J., Buettner G.R. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim. Biophys. Acta 2012, 1826(2):443-457. 10.1016/j.bbcan.2012.06.003.
37. Cossins E., Lee R., Packer L. ESR studies of vitamin C regeneration, order of reactivity of natural source phytochemical preparations. Biochem. Mol. Biol. Int. 1998, 45(3):583-597.
38. Linster C.L., Van Schaftingen E., Biosynthesis Vitamin C. recycling and degradation in mammals. Biochem. J. 2007, 274(1):1-22. 10.1111/j.1742-4658.2006.05607.x.
39. May J.M., Qu Z.C., Cobb C.E. Extracellular reduction of the ascorbate free radical by human erythrocytes. Biochem. Biophys. Res. Commun. 2000, 267(1):118-123. 10.1006/bbrc.1999.1906.
40. VanDuijn M.M., Tijssen K., VanSteveninck J., Van Den Broek P.J., Van Der Zee J. Erythrocytes reduce extracellular ascorbate free radicals using intracellular ascorbate as an electron donor. J. Biol. Chem. 2000, 275(36):27720-27725. 10.1074/jbc.M910281199.